Non-alcoholic fatty liver disease

Area of Science:

• Hepatology
• Internal Medicine
• Gastroenterology

Background:

• Non-alcoholic fatty liver disease (NAFLD) is a prevalent chronic liver condition impacting global health.
• Insulin resistance and oxidative stress are key factors in NAFLD development.
• NAFLD encompasses a spectrum from simple steatosis to advanced fibrosis and cirrhosis.

Purpose of the Study:

• To review the diagnostic and prognostic significance of various evaluation methods for NAFLD.
• To discuss the current therapeutic landscape and future directions for NAFLD management.
• To highlight the role of liver biopsy in assessing NAFLD severity and patient outcomes.

Main Methods:

• Review of clinical, biochemical, and imaging studies for NAFLD diagnosis.
• Emphasis on liver biopsy as the gold standard for diagnosis and prognosis.
• Analysis of current treatment strategies, including lifestyle modifications, metabolic control, and emerging pharmacological therapies.

Main Results:

• Liver biopsy provides the most sensitive and specific diagnostic and prognostic information for NAFLD.
• Simple steatosis has a favorable prognosis, but NAFLD can progress to severe liver damage.
• Current medical therapies, including metabolic control and weight reduction, show inconsistent results.
• Pharmacological treatments are under investigation, and liver transplantation is an option for end-stage disease.

Conclusions:

• NAFLD is a significant health concern with a variable prognosis.
• Effective medical therapies are limited, necessitating ongoing research and development.
• Liver transplantation is a viable option for advanced NAFLD but carries a risk of recurrence.